Dr. Charles Cho, MD

Dr. Cho practices at St. Vincent Eye Surgery Medical Center in Los Angeles, California.

Dr. Cho's NPI, 1053512566, was assigned on May 30, 2007. Dr. Cho holds Nevada license 13530.

Dr. Cho's primary practice is St. Vincent Eye Surgery Medical Center, at 201 S Alvarado St, Los Angeles, CA 90057 in Los Angeles County. The practice phone is (213) 483-0150.

Dr. Cho's primary practice is St. Vincent Eye Surgery Medical Center in Los Angeles, California. Dmand AI also links Dr. Cho to 1 dialysis center and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cho practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Cho's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Cho's licenses on file in 2 states: Nevada and Arizona.

CMS data shows 121 Medicare services from Dr. Cho across 1 procedure code in 2024, all of them office visits, for 29 Medicare patients. Medicare paid $9,116 for them. Every service was in an office.

CMS counts 29 Medicare patients who saw Dr. Cho in 2024. The largest group is 85 and over, with 11 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 3.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cho's median patient age at 74, with 49% women.

In 2024, Dr. Cho wrote 15,461 Medicare Part D claims for 1,126 patients. 78% of them were for generic drugs. CMS names the drug for 14,829 of them, across 140 drugs with 11 or more claims each, at $2,394,182 in total drug cost. In 2023, CMS named 13,750 claims across 131 drugs.

Dr. Cho accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 10 papers to Dr. Cho, published from 2010 to 2023. 2011 was the busiest year, with 4. The most frequent topics are Cell Proliferation, Cell Line, Tumor and Mice, Inbred C57BL. Dr. Cho has published most often in ACS Chem Biol. Dr. Cho's most frequent co-authors are James C. Watson, MD, Jonathan Chang, MD and Christine Chen, MD.

CMS Open Payments shows 914 general payments to Dr. Cho from 46 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 33% of the total. Janssen Pharmaceuticals, Inc paid the most, $54,111.